January 19, 2018 / 1:07 PM / a year ago

BUZZ-Intellipharmaceutics International: Jumps after brokerage starts with 'buy'

** Canadian drug developer’s U.S.-listed shares up 17.5 pct at $0.94 premarket; second biggest pct gainer among Nasdaq-listed stocks

** H.C. Wainwright starts coverage with “buy”, PT $2.50; says IPCI is underrated

** Believes IPCI to be underrated based on its focus on development and sale of high-value generic medications, improved formulations of existing drugs, among other things - H.C. Wainwright

** Analysts say company has a portfolio of generic drug filings that is comparable to an entity 10 times its size

** Brokerages bullish on stock: all 3 brokerages covering stock rate IPCI “buy” or higher; their median PT is $3

** Stock had risen fallen 71.8 pct in 2017 (Reporting by Amy Caren Daniel in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below